Literature DB >> 10906003

Compliance rate and associated factors for entering an alcohol brief intervention treatment programme.

M Aalto1, P Sillanaukee.   

Abstract

The study aim was to ascertain the compliance rate and to compare associated factors among heavy drinkers willing and unwilling to enter an alcohol brief intervention treatment programme. Patients aged 20-60 years visiting five primary healthcare clinics for any reason were both asked to complete a health questionnaire and interviewed to identify early phase heavy drinkers and to collect sociodemographic and health data. About half of the heavy drinkers (487/1011) complied with a recommendation for brief intervention. Gender, age, drinking variables, smoking, and exercise were associated with compliance. Women and young adults are subgroups of heavy drinkers whose compliance was lower than others and special attention should be given to them when planning brief intervention strategies.

Entities:  

Mesh:

Year:  2000        PMID: 10906003     DOI: 10.1093/alcalc/35.4.372

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  3 in total

1.  Age differences in outcomes among patients in the "Stimulant Abuser Groups to Engage in 12-Step" (STAGE-12) intervention.

Authors:  Sharon B Garrett; Suzanne R Doyle; K Michelle Peavy; Elizabeth A Wells; Mandy D Owens; Kathy Shores-Wilson; Jessica DiCenzo; Dennis M Donovan
Journal:  J Subst Abuse Treat       Date:  2017-10-28

Review 2.  Will emergency and surgical patients participate in and complete alcohol interventions? A systematic review.

Authors:  Bolette Pedersen; Kristian Oppedal; Lisa Egund; Hanne Tønnesen
Journal:  BMC Surg       Date:  2011-09-23       Impact factor: 2.102

3.  Improvements in readiness to change and drinking in primary care patients with unhealthy alcohol use: a prospective study.

Authors:  Nicolas Bertholet; Nicholas J Horton; Richard Saitz
Journal:  BMC Public Health       Date:  2009-04-09       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.